Ankara University Medical Faculty Cebeci Hospital

Ankara 6100

1 studies enrolling now · 7 studies all time

What they study most

Multiple Myeloma, Myelodysplastic Syndromes, Refractory Metastatic Gastric Cancer, Relapsed and/or Refractory Multiple Myeloma, Urinary Incontinence

Studies at this site

• A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions — Recruiting now
• An Observational Study of Presentation, Treatment Patterns, and Outcomes in Multiple Myeloma Participants — Stopped early
• Study of TAS-102 or Placebo Plus BSC in Patients With Metastatic Gastric Cancer — Completed
• Safety and Efficacy of Pomalidomide, Bortezomib and Low-dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma — Completed
• A Study of Ixazomib, Given With Dexamethasone in Adults With Multiple Myeloma — Completed
• A Study of Luspatercept (ACE-536) to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes — Completed
• Study of OnabotulinumtoxinA (BOTOX®) for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients — Completed